Clearbridge Investments LLC Has $317.69 Million Holdings in Haleon PLC Sponsored ADR $HLN

Clearbridge Investments LLC cut its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 5.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,423,276 shares of the company’s stock after selling 1,924,656 shares during the quarter. Clearbridge Investments LLC owned about 0.71% of Haleon worth $317,689,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of HLN. Norges Bank acquired a new stake in shares of Haleon during the fourth quarter worth $163,529,000. Natixis Advisors LLC increased its position in shares of Haleon by 429.8% during the fourth quarter. Natixis Advisors LLC now owns 10,003,941 shares of the company’s stock worth $101,140,000 after buying an additional 8,115,633 shares during the period. Bank of America Corp DE increased its position in shares of Haleon by 116.7% during the second quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after buying an additional 6,669,923 shares during the period. Optiver Holding B.V. acquired a new stake in shares of Haleon during the third quarter worth $45,593,000. Finally, JPMorgan Chase & Co. increased its position in shares of Haleon by 36.6% during the third quarter. JPMorgan Chase & Co. now owns 11,984,672 shares of the company’s stock worth $107,503,000 after buying an additional 3,207,986 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Trading Up 1.8%

NYSE:HLN opened at $9.13 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $40.42 billion, a price-to-earnings ratio of 23.40, a PEG ratio of 2.08 and a beta of 0.13. The firm has a fifty day simple moving average of $9.43 and a two-hundred day simple moving average of $9.93. Haleon PLC Sponsored ADR has a 12 month low of $8.65 and a 12 month high of $11.28.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Saturday, February 14th. The company reported $6.32 EPS for the quarter. The company had revenue of $3.65 billion during the quarter. Analysts expect that Haleon PLC Sponsored ADR will post 0.56 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Haleon from a “hold” rating to a “buy” rating in a research report on Saturday, March 21st. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Finally, Argus upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, March 17th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Haleon has a consensus rating of “Moderate Buy”.

Haleon Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.